1h Free Analyst Time
Global Pediatric Medicines Market 2020-2024Speak directly to the analyst to clarify any post sales queries you may have.
The publisher has been monitoring the pediatric medicines market and it is poised to grow by $ 27.71 bn during 2020-2024 progressing at a CAGR of 5% during the forecast period. The reports on the pediatric medicines market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven formulatory advancement, high pediatric population, and rapid environmental deterioration resulting in several allergic conditions. In addition, formulatory advancement is anticipated to boost the growth of the market as well.
The pediatric medicines market analysis include type segments and geographic segments.
The pediatric medicines market is segmented as below:
By Type
- Respiratory diseases
- Infectious diseases
- Gastrointestinal diseases
- CNS diseases
- Oncological diseases
- Others
By Geographic Landscape
- Asia
- Europe
- North America
- ROW
This study identifies inorganic growth strategies as one of the prime reasons driving the pediatric medicines market growth during the next few years. Government initiatives, and oral soluble films will lead to sizable demand in the market.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters.
The pediatric medicines market covers the following areas:
- Pediatric Medicines Market sizing
- Pediatric Medicines Market forecast
- Pediatric Medicines Market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading pediatric medicines market vendors that include AbbVie Inc., Bayer AG, F. Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, Johnson & Johnson, Merck & Co. Inc., Novartis AG, Pfizer Inc., Sanofi, and Takeda Pharmaceutical Co. Ltd.. Also, the pediatric medicines market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.
Table of Contents
Executive Summary
Market Landscape
Market Sizing
Five Forces Analysis
Market Segmentation by Other 1
Customer landscape
Geographic Landscape
Drivers, Challenges, and Trends
Vendor Landscape
Vendor Analysis
Appendix
List of Exhibits
Executive Summary
The publisher recognizes the following companies as the key players in the global pediatric medicines market: AbbVie Inc., Bayer AG, F. Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, Johnson & Johnson, Merck & Co. Inc., Novartis AG, Pfizer Inc., Sanofi, and Takeda Pharmaceutical Co. Ltd..Commenting on the report, an analyst from the research team said:"The latest trend gaining momentum in the market is the inorganic growth strategies."
According to the report, one of the major drivers for this market is the formulatory advancement.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AbbVie Inc.
- Bayer AG
- F. Hoffmann-La Roche Ltd.
- GlaxoSmithKline Plc
- Johnson & Johnson
- Merck & Co. Inc.
- Novartis AG
- Pfizer Inc.
- Sanofi
- Takeda Pharmaceutical Co. Ltd.
